FDA Inspection 1038536 — Rubicon Research Limited
The FDA completed an inspection of Rubicon Research Limited on Nov 20, 2017 in Thane. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 20, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Thane (India)